The GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTNEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →
CBL-514 β€’ Research evidence

CBL-514 Trial Registry: A Study-Reading Checklist

Quick answerA CBL-514 trial number identifies one study, not the whole development program. Match the identifier, population, endpoints and record date before combining a registry entry with a paper or announcement.

Published November 14, 2026 Β· Disguised Alpha Β· Source-linked research guide

Research education only. These notes do not provide instructions for human use or establish that a supplier’s material is equivalent to a clinical study formulation.

Start with the identifier

The 2026 CBL-514 MRI paper identifies its trial as NCT05736107. That identifier is a more reliable starting point than a headline containing β€œPhase 2,” because more than one study can share the same phase and compound name.[1]

Our suggested research worksheet starts with a row for the NCT identifier, followed by separate links for the registry, publication and any sponsor update. Keep the publication year separate from the dates when participants were enrolled. A later paper may describe work completed years earlier.

Separate the plan from the results

ClinicalTrials.gov distinguishes estimated enrollment from actual enrollment and provides separate information about study design and posted results.[2] A planned sample size is not a final analysis denominator. Likewise, a scheduled completion date does not establish that the outcome was achieved.

Use three columns in your notes: planned, reported and unresolved. For example, place a registry’s planned imaging endpoint under planned; put the paper’s reported analysis population under reported; leave an unexplained difference under unresolved. Do not silently replace one with the other.

This approach also prevents duplicate counting. A conference abstract, a sponsor announcement and a journal article may all describe the same participants. They are three documents, not necessarily three independent studies.

A practical comparison record

  • Study identity: registry number and protocol identifier.
  • Research question: anatomical region and named outcome.
  • Design: comparator, allocation and masking.
  • Population: eligibility, actual enrollment and analyzed count.
  • Timing: endpoint visit and document version date.
  • Evidence: results table, paper and unresolved differences.

Archive the date of your review. If a record changes, compare versions before interpreting that change. An amendment can be legitimate; what matters is its timing, explanation and effect on the question being answered. This checklist organizes evidence and does not verify the composition of a supplier’s CBL-514 vial.

Frequently asked questions

Does a registered CBL-514 study prove that results are available?

No. Registration describes a study record. Look separately for posted results and a publication, and match both to the same identifier.

Should two papers with the same trial number count twice?

Treat them as potentially overlapping reports until you establish that the participant groups or analyses are independent.

Continue your CBL-514 research

Compare the original study evidence with the documentation for the specific material you are reviewing.

Sources and further reading

  1. Lorenc et al., 2026 CBL-514 Phase IIb publication
  2. ClinicalTrials.gov: how to read a study record

Publisher disclosure: Disguised Alpha is a research-material supplier. This guide is an educational interpretation of the linked sources, not an independent clinical review or a statement of regulatory approval.

References describe the studies or methods identified in the text. They do not independently certify the composition, clinical suitability or performance of Disguised Alpha products.

βœ“
Loading...
25% offGLPs15% off automaticallyUse code GLP or any code for 25% off0days00hrs00min00secShop the sale  →Shop